Meg Elias
Corporate Officer/Principal bei ARCUTIS BIOTHERAPEUTICS, INC.
Profil
Meg Elias is currently the Vice President of Clinical Operations at Arcutis Biotherapeutics, Inc. Her former position was as Head of Clinical Operations at Kite Pharma, Inc. She received her undergraduate degree from Cedar Crest College.
Aktive Positionen von Meg Elias
| Unternehmen | Position | Beginn |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.2019 |
Ehemalige bekannte Positionen von Meg Elias
| Unternehmen | Position | Ende |
|---|---|---|
| KITE PHARMA INC | Corporate Officer/Principal | 01.12.2018 |
Ausbildung von Meg Elias
| Cedar Crest College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
